Job Description
Alliance Manager - Rare Oncology
Job Requisition ID: 32765
Department: SALES
Category: Commercial - Sales
Location: UK Field
Date: 23 May 2026
SERB is a fast-growing global specialty pharma company designed to address rare and urgent conditions by delivering life-saving medicines when time and complexity leave no room for failure.
We operate end-to-end across 100+ countries, ensuring 70+ essential medicines for rare diseases, emergency care, and medical countermeasures reach patients and clinicians with urgency – wherever and whenever they are needed.
Shaped over the past 25 years by an entrepreneurial, disruptive spirit, SERB combines the focus and agility of a biotech with the scale, reach, and reliability of a global pharmaceutical company — always grounded in medical purpose, not corporate convention.
Our 600+ employees are driven by three core values:
Job Requisition ID: 32765
Department: SALES
Category: Commercial - Sales
Location: UK Field
Date: 23 May 2026
SERB is a fast-growing global specialty pharma company designed to address rare and urgent conditions by delivering life-saving medicines when time and complexity leave no room for failure.
We operate end-to-end across 100+ countries, ensuring 70+ essential medicines for rare diseases, emergency care, and medical countermeasures reach patients and clinicians with urgency – wherever and whenever they are needed.
Shaped over the past 25 years by an entrepreneurial, disruptive spirit, SERB combines the focus and agility of a biotech with the scale, reach, and reliability of a global pharmaceutical company — always grounded in medical purpose, not corporate convention.
Our 600+ employees are driven by three core values:
- Patients first, always - Patient...
Ready to Apply?
Submit your application today and join our talented team at SERB Pharmaceuticals.
Submit ApplicationJob Details
- Location United Kingdom, United Kingdom
- Job Type fulltime
- Category Other Management Occupations
- Posted Date July 02, 2026
- Application Deadline August 11, 2026